Healthcare Services

Global cell lysis and disruption market analysis (2026–2030)

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Cell Lysis And Disruption Market Between 2026 And 2030?

The cell lysis and disruption market size has experienced significant growth in recent years. This market is expected to expand from $5.34 billion in 2025 to $5.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be linked to the broadening of molecular biology research activities, the increased utilization of recombinant protein production, the rise in academic life sciences research, the surging adoption of microbial fermentation processes, and the accessibility of advanced laboratory instruments.

The cell lysis and disruption market size is forecast to demonstrate significant growth in the upcoming years, with projections indicating it will reach $8.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This anticipated expansion during the forecast period is fueled by an increasing demand for biologics manufacturing, growing investments in cell and gene therapy research, the broadening of proteomics and genomics studies, a heightened emphasis on automation within laboratories, and the expanded adoption of high-throughput screening platforms. Key trends anticipated in this period include the rising adoption of mechanical cell disruption systems, an increased use of high-purity lysis reagents, a growing requirement for scalable cell processing solutions, the expansion of automated sample preparation workflows, and an enhanced focus on achieving both yield and reproducibility.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-disruption-global-market-report

What Major Factors Are Driving The Cell Lysis And Disruption Market Forward?

An escalating emphasis on personalized medicine is projected to propel the expansion of the cell lysis and disruption market moving forward. This medical strategy involves customizing treatment and care based on the distinct traits, like genetic makeup and lifestyle, of individual patients. The need for personalized medicine is growing due to progress in genomic technologies, which facilitate more accurate identification of genetic variations responsible for diseases, thus enabling specific and highly effective treatments. This increasing need for personalized medicine necessitates cell lysis and disruption, as these procedures are crucial for obtaining Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), and proteins from patient samples, which is vital for the molecular analysis needed to formulate customized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization and the U.S. Food and Drug Administration (USFDA), a US-based regulatory authority, approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from 6 personalized treatments in 2022. Consequently, the heightened attention on personalized medicine will stimulate the growth of the cell lysis and disruption market.

How Is The Cell Lysis And Disruption Market Broken Down By Segment Categories?

The cell lysis and disruption market covered in this report is segmented –

1) By Product: Reagents And Consumables, Instruments

2) By Cell Type: Bacteria Cells, Mammalian Cells, Plant Cells, Yeast Or Fungi Or Algae

3) By Application: Cell Organelle Isolation, Protein Isolation, Downstream Processing, Nucleic Acid Isolation

4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Reagents And Consumables: Enzymes, Detergent Solutions, Kits And Reagents

2) By Instruments: Homogenizers, Sonicator, Microfluidizer, Other Instruments

Which Trends Are Impacting The Progress Of The Cell Lysis And Disruption Market?

Leading companies operating within the cell lysis and disruption market are directing their efforts toward developing advanced solutions, such as single-cell microfluidic platforms, to enhance the capabilities and efficiency of single-cell analysis for researchers engaged in microbial genomics. A single-cell microfluidic platform is defined as a miniaturized device that accurately isolates, manipulates, and analyzes individual cells by managing minute fluid volumes within microchannels, thereby facilitating high-throughput and automated single-cell studies. As an illustration, in January 2024, Atrandi Biosciences Inc., a biotechnology firm located in Lithuania, launched its Flux platform along with the Single-Microbe DNA Barcoding Kit. These specific products leverage semi-permeable capsule (SPC) technology, which permits the efficient isolation and lysis of individual microbial cells while simultaneously upholding the integrity of subsequent reactions. This innovative platform provides high-throughput functionalities, enabling precise microbial genome quantification and DNA sequencing, which is essential for advancing microbial genomics and single-cell analysis. Ultimately, these solutions are engineered to streamline and improve workflows, making high-resolution, single-cell analysis more accessible and effective for researchers across various scientific domains.

Which Players Are Present In The Cell Lysis And Disruption Market Space?

Major companies operating in the cell lysis and disruption market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company (BD), Agilent Technologies Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Eppendorf AG, Miltenyi Biotec GmbH, Takara Bio Inc., Promega Corporation, New England Biolabs Inc., Covaris LLC, Microfluidics International Corp., Claremont BioSolutions LLC, Qsonica LLC, Zymo Research Corp., BioVision Inc., Beckman Coulter Inc., Sartorius AG, PerkinElmer Inc.

Get The Full Cell Lysis And Disruption Market Report:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-disruption-global-market-report

Which Region Represents The Largest Share Of The Cell Lysis And Disruption Market?

North America was the largest region in the cell lysis and disruption market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell lysis and disruption market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Lysis And Disruption Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-disruption-global-market-report

Browse Through More Reports Similar to the Global Cell Lysis And Disruption Market 2026, By The Business Research Company

Cell Harvesting Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-harvesting-global-market-report

Cell Separation Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-separation-technologies-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795